MétaCan
Menu
← Back to cohort

Population-based evaluation of second-line palliative chemotherapy (SCT) versus erlotinib (E) in advanced non-small cell lung cancer (NSCLC) patients (pts).

2014· article· en· W2597980213 on OpenAlexaff
Krista Noonan, Cheryl Ho, Sophie Sun, Barbara Melosky, Janessa Laskin, Nevin Murray

Bibliographic record

VenueJournal of Clinical Oncology · 2014
Typearticle
Languageen
FieldMedicine
TopicLung Cancer Treatments and Mutations
Canadian institutionsBC Cancer Agency
Fundersnot available
KeywordsMedicineDocetaxelErlotinibInternal medicineVinorelbineLung cancerPemetrexedOncologyPopulationCancerPerformance statusProportional hazards modelHazard ratioChemotherapyEpidermal growth factor receptorConfidence intervalCisplatin

Abstract

fetched live from OpenAlex

e19080 Background: Several SCT options improve overall survival (OS) in advanced NSCLC. Recent evidence questions efficacy of E in EGFR wild type (WT) pts. Our objective was to evaluate the clinical effectiveness of SCT versus E in a diverse community population. Methods: The British Columbia Cancer Agency (BCCA) provides comprehensive cancer care to a population of 4.5 million. A retrospective analysis of all referred pts with stage 3b/4 NSCLC diagnosed in BC in 2009 who received SCT was performed. Kaplan-meier method with log-rank and Cox-proportional hazards model was used for survival analyses. Results: Of 748 pts seen by medical oncology, 415 (55%) had first-line CT, and 187 (25%) received SCT. Of these 107 (57%) received E, 55 (29%) pemetrexed (P), 11 (6%) docetaxel (D), 8 (4%) vinorelbine (V), 5 (3%) platinum-doublet, 1 an investigational drug. EGFR status was known in 44%. E treated pts were older, with a worse ECOG, and less third-line CT than SCT (P,V,D). PFS was longer in E than SCT at 2.3 mos (CI 1.2-3.4), and 2.1 mos (CI 1.5-2.7), p=0.01. OS was similar in the E and SCT at 8.2 mos (CI 6.9-9.4), and 6.8 mos (CI 3.9-9.7) respectively, p=0.203. Controlling for age and ECOG, the PFS HR was 1.00 (CI 0.44-2.3), p=0.99; and the OS HR was 1.04 (CI 0.41-2.6) for E treated pts. In the subgroup of EGFR WT pts, mPFS and mOS were statistically similar in E and SCT gps (Table). Conclusions: Although a higher proportion of pts who received E were older, poorer ECOG and had less subsequent CT, PFS and OS were similar to SCT pts. The effectiveness of E versus SLC will be evaluated in a larger cohort of pts. E (n=107) SCT (n=74) P value Sex Male 51 44 0.08 Female 56 30 Age, range 67, 44-80 63, 46-76 0.04 ECOG PS 0-2 62 54 0.03 3-4 45 20 Geographical site Rural 19 10 0.37 Urban 88 63 Unknown 0 1 Histology Non-squamous 79 52 0.45 Squamous 16 9 Not otherwise specified 12 13 EGFR WT 18 13 0.96 Mutated 1 1 Unknown 69 60 CT Third-line Fourth-line Fifth-line 36 8 2 45 6 3 <0.0001 0.88 0.41 Number cycles Third-line Fourth-line Fifth-line 3 1.5 2 2 2 1 0.82 0.90 0.50 Entire cohort, mos (95% CI) mPFS mOS 2.3 (1.2-3.4) 8.2 (7.0-9.4) 2.1 (1.4-2.7) 6.8 (4.3-9.3) 0.01 0.20 EGFR WT subgroup mPFS mOS 1.4 (1.9-3.3) 4.7 (3.5-6.9) 2.6 (1.9-3.2) 5.5 (2.8-8.2) 0.86 0.65

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.004
metaresearch head score (Gemma)0.005
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.004
Threshold uncertainty score0.019

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0040.005
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0010.001
Science and technology studies0.0000.001
Scholarly communication0.0010.001
Open science0.0010.001
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.076
GPT teacher head0.510
Teacher spread0.434 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2014
Admission routes1
Has abstractyes

Explore more

Same venueJournal of Clinical Oncology→Same topicLung Cancer Treatments and Mutations→French-language works237,207→